About Evonik
Evonik is a company based in Essen (Germany) founded in 1847. It operates as a Professional Services, Direct-to-Consumer (D2C), and Circular Economy. The company has 93 employees as of April 08, 2024. Evonik has completed 16 acquisitions, including Alkion BioInnovations, Dr Straetmans and Dynasylan. Evonik offers products and services including SEPURAN® Green, AEROXIDE®, and MaxiPure® Polysorbate 80. Evonik operates in a competitive market with competitors including LanzaTech, Again, Manus Bio, Proklean Technologies and Calyxia, among others.
- Headquarter Essen, Germany
- Employees 93 as on 08 Apr, 2024
- Stage Public
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evonik Industries Ag
- Date of Incorporation 07 Aug, 1992
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$24.8 M (USD)60.37as on Mar 31, 2023
-
Net Profit
$929.28 K (USD)305.8as on Mar 31, 2023
-
EBITDA
$2.04 M (USD)307.87as on Mar 31, 2023
-
Latest Funding Round
$312.1 K (USD), Grant
Jun 01, 2021
-
Investors
European Union
& 2 more
-
Employee Count
93
as on Apr 08, 2024
-
Investments & Acquisitions
Alkion BioInnovations
& 15 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evonik
Evonik offers a comprehensive portfolio of products and services, including SEPURAN® Green, AEROXIDE®, and MaxiPure® Polysorbate 80.
Biogas processing is enhanced by reducing greenhouse emissions effectively.
Battery performance is improved for electric vehicles with safety.
Drug formulations are supported with high-purity surfactant for injectables.
People of Evonik
Unlock access to complete
Unlock access to complete
Software Development Team
80 people
Product Management Team
34 people
Sales and Marketing
27 people
Leadership Team
22 people
Supervisory Team
12 people
Finance and Accounting
12 people
Project Team
11 people
Head Team
10 people
Unlock access to complete
Funding Insights of Evonik
Investors in Evonik
Evonik has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, BAFA and CVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Business and energy news is delivered via an online platform.
|
Locked | Locked | Locked |
Investor details for Evonik
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evonik
Evonik has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include Alkion BioInnovations, Dr Straetmans and Dynasylan.
Investment portfolio details for Evonik
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Air purifiers, surface sanitizers, and vegetable wash solutions are provided.
|
Locked | Locked | 2020 | Locked | |
|
Dermatological drugs are manufactured by InnoHealth Group in Spain.
|
Locked | Locked | 2014 | Locked | |
|
Hydrogen peroxide, peracetic acid, and persulfates are manufactured and supplied.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Evonik
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Evonik
Detailed financials for Evonik
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evonik Comparisons
Peer comparison for Evonik
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evonik
Evonik operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LanzaTech, Again, Manus Bio, Proklean Technologies and Calyxia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Waste carbon is treated via a bio-processing platform.
|
|
| Locked | Locked | Locked |
Chemicals and fertilizers are produced from industrial CO2 waste.
|
|
| Locked | Locked | Locked |
Phytochemicals are developed using microbial fermentation processes.
|
|
| Locked | Locked | Locked |
Probiotic-based cleaning agents are manufactured for industrial use.
|
|
| Locked | Locked | Locked |
Green chemicals are developed using microcapsule technology for sustainability.
|
Detailed competitors of Evonik
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evonik
Complete news archive for Evonik
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evonik
Evonik was founded in 1847 and raised its 1st funding round 161 years after it was founded.
Evonik is headquartered in Essen, Germany. It is registered at Essen, North Rhine-westphalia, Germany.
Christian Kullmann is the current CEO of Evonik.
As of Apr 08, 2024, the latest employee count at Evonik is 93.
Annual revenue of Evonik is $24.8M as on Mar 31, 2023.
Evonik is established as a global leader in specialty chemicals, focusing on innovative solutions across various industries. Operations are conducted in sectors such as automotive, healthcare, energy, and consumer goods. Advanced technologies are developed for applications like additive manufacturing, biopharmaceuticals, and green hydrogen. Sustainable practices are integrated through circular economy initiatives. Tailor-made products and solutions are provided to enhance customer competitiveness. Worldwide locations are maintained to support diverse market needs effectively.
Evonik's top competitors include Manus Bio, LanzaTech and Mint Innovation.
Evonik offers SEPURAN® Green, AEROXIDE®, and MaxiPure® Polysorbate 80.
Evonik has made 16 acquisitions, including Alkion BioInnovations, Dr Straetmans, and Dynasylan.
Evonik has 3 investors. Key investors include European Union, BAFA, and CVC.